Expression of epidermal growth factor receptor in the inverted papilloma and squamous cell carcinoma of nasal cavity

Rhinology

Abstract

The present study was undertaken to compare positive rate of immunostaining (PR) and positive intensity of immunostaining (PI) of epidermal growth factor receptor (EGFR) in inverted papilloma (IP), synchronous carcinoma with IP and metachronous carcinoma with IP of the nasal cavity. Ten subjects with nasal polyps, ten subjects with inverted papilloma (IP), five subjects with synchronous carcinoma with IP and ten subjects with metachronous carcinoma with IP were enrolled with a control group of ten subjects of inferior turbinate. Each specimen was divided into two portions: one for RNA isolation and the other for detection of EGFR protein. Positive rate of immunostaining, positive intensity of immunostaining for EGFR protein and EGFR mRNA were significantly up-regulated in the IP, synchronous carcinoma with IP and metachronous carcinoma with IP when comparing polyp and normal mucosa. A role for EGFR in the malignant transformation from IP to SCC of the nasal cavity is suggested.

Keywords

Epidermal growth factor receptor Inverted papilloma Synchronous carcinoma Metachronous carcinoma 

References

  1. 1.
    Shimizu N, Wang Y, Minoshima S, Ishitoya J (1994) Detection of epidermal growth factor receptor gene amplification in human squamous cell carcinoma using fluorescence in situ hybridization. Jpn J Cancer Res 85:567–571PubMedGoogle Scholar
  2. 2.
    Ford AC, Grandis JR (2003) Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 25:67–73. doi:10.1002/hed.10224 PubMedCrossRefGoogle Scholar
  3. 3.
    Miyaguchi M, Olofsson J, Hellquist HB (1991) Expression of epidermal growth factor receptor in glottic carcinoma and its relation to recurrence after radiotherapy. Clin Otolaryngol 16:466–469CrossRefPubMedGoogle Scholar
  4. 4.
    Issing WJ, Wustrow TPU, Heppt W (1993) Oncogenes related to head and neck cancer. Anticancer Res 13:2541–2552PubMedGoogle Scholar
  5. 5.
    Irisj JC, Bernstein A (1993) Oncogenes in head and neck cancer. Laryngoscope 103:42–52Google Scholar
  6. 6.
    Ke LD, Adler-Storthz K, Clayman GL, Yung AWK, Chen Z (1998) Differential expression of epidermal growth factor receptor in human head and neck cancers. Head Neck 20:320–327PubMedCrossRefGoogle Scholar
  7. 7.
    Furuta Y, Takasu T, Asai T, Yoshimura S, Tokuchi F, Shinohara T, Nagashima K, Inuyama Y (1992) Clinical significance of the epidermal growth factor receptor gene in squamous cell carcinoma of the nasal cavities and paranasal sinuses. Cancer 69:358–362PubMedCrossRefGoogle Scholar
  8. 8.
    Miyaguchi M, Sakai S, Olofsson J, Kuwababa H, Sakamoto H (1993) Prognostic significance of epidermal growth factor receptor in squamous cell carcinoma of maxillary sinus. Eur Arch Otorhinolaryngol 249:478–481PubMedCrossRefGoogle Scholar
  9. 9.
    Mizaguchi H, Komiyama S, Matsui K, Hamanaka R, Ono M, Kiue A, Kobayashi M, Shimizu N, Welgus HG, Kuwano M (1991) The response to epidermal growth factor of human maxillary tumor cells in terms of growth, invasion and expression of proteinase inhibitors. Int J Cancer 49:738–743CrossRefGoogle Scholar
  10. 10.
    Grandis JR, Tweardy DJ (1993) Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogensis in head and neck cancer. Cancer Res 53:3579–3584PubMedGoogle Scholar
  11. 11.
    Grandis JR, Melhem MF, Barnes EL, Tweardy DJ (1996) Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 78:1284–1292CrossRefGoogle Scholar
  12. 12.
    Grandis JR, Chakraborty A, Zeng Q, Melhem MF (1998) Tweardy DJ. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous cell carcinoma but not normal mucosal epithelial cells. J Cell Biochem 69:55–62PubMedCrossRefGoogle Scholar
  13. 13.
    Shin DM, RO JY, Hong W, Hittelman WN (1994) Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 53:3153–3159Google Scholar
  14. 14.
    Soukos Ns, Hamblin MR, Keel S, Fabian RL, Deutsch TF, Hasan T (2001) Epidermal growth factor receptor-targeted immuniphotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res 61:4490–4496PubMedGoogle Scholar
  15. 15.
    Yamaguchi KT, Shapshay SM, Incze JS, Vaughan CW, Strong S (1979) Inverted carcinoma and squamous cell carcinoma. J Otolaryngol 8:171–178PubMedGoogle Scholar
  16. 16.
    Benninger MS, Roberts JK, Sebek BA, Levine HL, Tucker HM, Lavertu P (1990) Inverted papilloma and associated squamous cell carcinoma. Otolaryngol Head Neck Surg 103:457–461PubMedGoogle Scholar
  17. 17.
    Christian VA, Partrick JB (2007) Risks of malignancy in inverted papilloma of the nose and paranasal sinuses. Curr Opin Otolaryngol Head Neck Surg 15:95–98CrossRefGoogle Scholar
  18. 18.
    Leon B (2002) Schneiderian Papillomas and Nonsalivary Glandular Neoplasms of the Head and Neck. Mod Pathol 15(3):279–297CrossRefGoogle Scholar
  19. 19.
    Hyams VJ (1971) Papillomas of the nasal cavity and paranasal sinuses: a clinicopathological study of 315 cases. Ann Otol Rhinol Laryngol 80:192–206PubMedGoogle Scholar
  20. 20.
    Cagle PT, Brown RW, Lebovitz ML (1994) P53 immunostaining in the differentiation of reactive processed from malignancy in pleural biopsy specimens. Hum Pathol 25:443–448PubMedCrossRefGoogle Scholar
  21. 21.
    Fang SY, Yan JJ, Ohyama M (1998) Assessment of p53 protein expression in human mucosa and benign and malignant lesions of the nasal cavity. Oncology 55:168–173PubMedCrossRefGoogle Scholar
  22. 22.
    Lesperance MM, Esclamado RM (1995) Squamous cell carcinoma arising in inverted papilloma. Laryngoscope 105:178–183PubMedCrossRefGoogle Scholar
  23. 23.
    Takeyama K, Fahy J, Nadel JA (2001) Relationship of epidermal growth factor receptors to goblet cell production in human bronchi. Am J Respir Crit Care Med 163:511–516PubMedGoogle Scholar
  24. 24.
    Takryama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, Grattan KM, Nadel JA (1999) Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci 96:3081–3086CrossRefGoogle Scholar
  25. 25.
    Lee HM, Malm L, Dabbagh K, Dao-Pick T, Ueki IF, Kim S, Shim JJ, Nadel JA (2001) Epidermal growth factor receptor signaling mediates regulation of rat nasal goblet cells. J Allergy Clin Immunol 107:1046–1050PubMedCrossRefGoogle Scholar
  26. 26.
    Kimura T, Majima Y, Guo Y, Yoshida T (2002) The effect of growth factors on the proliferation and differentiation of human nasal gland cells. Arch Otolaryngol Head Neck Surg 128:578–582PubMedGoogle Scholar
  27. 27.
    Burgel PR, Escudier E, Coste A, Dao-Pick T, Ueki IF, Takeyama K, Shim JJ, Murr AH, Nadel JA (2000) Relation of epidermal growth factor receptor expression to goblet cell hyperplasia in nasal polyps. J Allergy Clin Immunol 106:705–712PubMedCrossRefGoogle Scholar
  28. 28.
    Miyaguchi M, Takeuchi T, Morimoto K, Takeshi K (1998) Correlation of epidermal growth factor and rediosensitivity in human maxillary carcinoma cell lines. Acta Otolaryngol (Stockh) 118:428–431CrossRefGoogle Scholar
  29. 29.
    Srinivasan M, Jewell SD (2001) Evaluation of TGF-alfa and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology 61:284–292PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  1. 1.Department of OtolaryngologyNational Cheng Kung University HospitalTainanTaiwan

Personalised recommendations